Active Ingredient(s): Drospirenone + Estetrol
FDA Approved: * April 15, 2021
Pharm Company: * MAYNE PHARMA
Category: Birth Control / Contraceptive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nextstellis Overview

Drospirenone/estetrol (E4/DRSP), sold under the brand names Estelle and Nextstellis among others,[3][1] is a fixed-dose combination medication of drospirenone, a progestin, and estetrol, an estrogen, which is used as a combined birth control pill for the prevention of pregnancy in women.[1][2] It is taken by mouth.[1][2] As of March 2021, it is approved in Canada and is pending approval in other co...

Read more Nextstellis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nextstellis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drospirenone + Estetrol
  • Tablet: 3mg + 14.2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nextstellis: (1 result)

Sorted by National Drug Code
  • 51862-258 NextstellisNextstellis Kit by Mayne Pharma

Drugs with one or more similar ingredients: (19 results)